IMB researchers are sharing their expertise in tackling drug-resistant bacteria with low and middle income countries, thanks to new funding from CARB-X.
Tackling antibiotic resistance and exploring the role of genomics in the novel coronavirus are the focus of new funding from the NHMRC, to fight infectious disease.